Member Login
ITOG Selumetinib Trial Achieves Accrual Goal! Congratulations to Principal Investigator: Alan Ho, MD at Memorial Sloan-Kettering Cancer [...]
ITOG is pleased to announce that Dr. Sophie Leboulleux has been elected as the newest international member [...]